Goodman Noah 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Goodman Noah（CIK 2060075）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-07-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 3,389 | $387,329 |
| 2026-06-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 买入 | 5,000 | $105,250 |
| 2026-06-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,500 | $272,500 |
| 2026-06-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,500 | $297,500 |
| 2026-06-22 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 买入 | 2,500 | $52,625 |
| 2026-06-22 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,500 | $247,500 |
| 2026-04-16 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 1,347 | $121,230 |
| 2026-04-10 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 买入 | 2,500 | $52,625 |
| 2026-04-10 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 3,094 | $268,002 |
| 2026-04-10 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,670 | $232,584 |
| 2026-04-10 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,500 | $222,500 |
| 2026-04-10 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 卖出 | 2,000 | $174,700 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Business Officer | 买入 | 9,225 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-02